| Product NDC: | 61314-044 |
| Proprietary Name: | Trifluridine |
| Non Proprietary Name: | trifluridine |
| Active Ingredient(s): | 10 mg/mL & nbsp; trifluridine |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61314-044 |
| Labeler Name: | Falcon Pharmaceuticals, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074311 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20010514 |
| Package NDC: | 61314-044-75 |
| Package Description: | 7.5 mL in 1 BOTTLE, PLASTIC (61314-044-75) |
| NDC Code | 61314-044-75 |
| Proprietary Name | Trifluridine |
| Package Description | 7.5 mL in 1 BOTTLE, PLASTIC (61314-044-75) |
| Product NDC | 61314-044 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | trifluridine |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20010514 |
| Marketing Category Name | ANDA |
| Labeler Name | Falcon Pharmaceuticals, Ltd. |
| Substance Name | TRIFLURIDINE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |